Management of the postchemotherapy residual mass Journal Article


Authors: Sheinfeld, J.; Bajorin, D.
Article Title: Management of the postchemotherapy residual mass
Abstract: The role of surgery in patients with advanced germ-cell tumors after chemotherapy has evolved substantially in the era of combined modality therapy. In evaluating patients for surgery after chemotherapy, the clinician must consider carefully the histologic type (seminoma versus nonseminomatous germ-cell tumors) of the primary tumor as well as the extent of the residual disease. Criteria designed to select patients with nonseminomatous tumors in whom the surgical histologic findings are negative are associated with substantial error. A normal radiographic evaluation in patients with nonseminomatous germ-cell tumors is not entirely predictive of negative pathology findings, and the treating physician must consider the risk of residual tumor despite a radiographic complete remission. In contrast, patients with seminoma have less potential for residual tumor, and the size of the residual disease permits more accurate selection of patients who still have malignancy. Continued research is needed to improve the sensitivity and specificity of patient selection for surgery after chemotherapy in order to limit the toxicity of curative therapy.
Keywords: cancer chemotherapy; human tissue; review; cisplatin; multimodality cancer therapy; patient selection; cancer radiotherapy; postoperative care; lymph node dissection; lung toxicity; neoplasm recurrence, local; lung resection; tumor marker; diagnosis; cancer size; testicular neoplasms; bleomycin; neoplasms, germ cell and embryonal; germ cell tumor; seminoma; human; male; priority journal
Journal Title: Urologic Clinics of North America
Volume: 20
Issue: 1
ISSN: 0094-0143
Publisher: W.B. Saunders Co-Elsevier Inc.  
Date Published: 1993-02-01
Start Page: 133
End Page: 143
Language: English
PUBMED: 8381994
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 March 2019 -- Source: Scopus
Citation Impact
MSK Authors
  1. Dean Bajorin
    657 Bajorin
  2. Joel Sheinfeld
    254 Sheinfeld